SHIV-KB9 infection of rhesus monkeys does not always cause disease-contribution of host immune factors and thymic output

Virology

Volumn 303, Issue 1, 2002, Pages 47-57

  Kourtis, Athena P ^a,e   Ibegbu, Christian C ^a,b   Scinicariello, Franco ^a   Oh, Chin Yih ^d   McClure, Harold M ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Antibody; Cytokines; Disease progression; Rhesus macaque; Simian human immunodeficiency virus; Thymus

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CLONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INOCULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN VIRUS; T LYMPHOCYTE; THYMUS; VIRUS INFECTION; VIRUS LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA MULATTA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036930366     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1600     Document Type: Article

References (24)

1. + T cell-generated suppressor factor and beta-chemokines by targeted iliac lymph node immunization in rhesus monkeys challenged with SHIV-89.6P by the rectal route. AIDS Res. Hum. Retroviruses 16, 381-392.
2. Chakrabarti, L., Cumont, M. C., Montagnier, L., et al. (1994). Variable course of primary simian immunodeficiency virus infection in lymph nodes. Relation to disease progression. J. Virol. 68, 6634-6643.
3. Champagne, P., Ogg, G. S., King, A. S., Knabenbans, C., Ellefsen, K., Nobile, M., Appay, V., Rizzardi, C., Fleury, S., Lipp, M., Forster, R., Rowland-Jones, S., Sekaly, R. P., McMichael, A., and Pantaleo, G. (2001). Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106-111.
4. Cole, K. S., Murphey-Corb, M., Narayan, O., Joag, S., Shaw, G., and Montelaro, R. (1998). Common themes of antibody maturation to simian immunodeficiency virus, Simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J. Virol. 72, 7852-7859.
5. Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan, J. L., Jamieson, B. D., Zack, J. A., Picker, L. J., and Koup, R. A. (1998). Changes in thymic function with age and during the treatment of HIV infection. Nature 396, 690-695.
6. + T cell depletion in macaques infected by a simian-human immunodeficiency virus. J. Virol. 75(12), 5646-5655.
7. Etemad-Moghadam, B., Sun, Y., Nicholson, E., Fernandes, M., Liou, K., Gomila, R., Lee, J., and Sodroski, J. (2000). Envelope glycoprotein determinants of increased fusogenicity in a pathogenic Simian-human immunodeficiency virus (SHIV-KB9) passaged in vitro. J. Virol. 74 (9), 4433-4440.
8. Harouse, J. M., Gettie, A., Chin How Tan, R., Blanchard, J., and Cheng-Meyer, C. (1999). Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284, 816-819.
9. + T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. J. Infect. Dis. 181, 1264-1272.
10. + cells in SHIV-infected macaques. AIDS Res. Hum. Retroviruses 16, 9-18.
11. + lymphocyte depletion in rhesus macaques. J. Virol. 71(6), 4218-4225.
12. Kozyrev, I. L., Ibuki, K., Shimada, T., Kuwata, T., Takemura, T., Hayami, M., and Miura, T. (2001). Characterization of less pathogenic infectious molecular clones derived from acute pathogenic SHIV-89.6P Stock virus. Virology 282, 6-13.
13. Kuroda, M., Schmitz, J., Barouch, D., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A., and Letvin, N. L. (1998). Analysis of Gag-specified cytotoxic T lymphocytes in simian immunodeficiency virus macaque (SIVmac)-infected Rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187, 1-9.
14. Larrson, M., Jin, X., Ramratnam, B., Ogg, G. S., Engelmayer, J., Demoitie, M. A., McMichael, A. J., Cox, W., Steinman, R. M., Nixon, D., and Bhardwaj, N. (1999). A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1 positive individuals. AIDS 13, 767-777.
15. Li, S. L., Kaaya, E., Ordonez, C., et al. (1995). Thymic immunopathology and progression of SIVsm infection in cynomolgus monkeys. J. Acquir. Immun. Def. Syndr. Hum. Retrovirol. 9, 1-10.
16. Lu, Y., Pauza, D., Lu, X., Montefiori, D., Miller, C. (1998). Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J. Acquir. Immun. Def. Syndr. Hum. Retrovirol. 19, 6-18.
17. McFarland, R., Douek, D., Koup, R., and Picker, L. J. (2000). Identification of a human recent thymic emigrant phenotype. Proceedings of the National Academy of Sciences 97, 4215-4220.
18. Mellors, J. W., Rinaldo, C. R., Gupta, P., et al. (1996). Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170.
19. Reimann, K., Li, J., Voss, G., Lekutis, C., Tenner-Racz, K., Racz, P., Lin, W., Montefiori, D., Lee-Parritz, D. E., Lu, Y., Collman, R. G., Sodroski, J., and Letvin, N. L. (1996). An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70, 3198-3206.
20. Reimann, K., Watson, A., Dailey, P., Lin, W., Lord, C. I., Steenbeke, T. D., Parker, R. A., Axthelm, M. K., and Karlsson, G. B. (1999). Viral burden and disease progression in rhesus macaques infected with chimeric simian-human immunodeficiency viruses. Virology 256, 15-21.
21. Shibata, R., Maldarelli, F., Siemon, C., Matano, T., Parta, M., Miller, G., Fredrickson, T., and Martin, M. (1997). Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 176, 362-376.
22. Sodora, D. L., Douek, D. C., Silvestri, G., Montgomery, L., Rosenzweig, M., Igarashi, T., Bernacky, B., Paul Johnson, R., Feingerg, M. B., Martin, M. A., and Koup, R. A. (2000). Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. Eur. J. Immunol. 30, 1145-1153.
23. Wallace, M., Waterman, P., Mitchen, J., Djavani, M., Brown, C., Trivedi, P., Horejsh, D., Dykhuizen, M., Kitabwalla, M., and Pauza, D. (1999). Lymphocyte activation during acute Simian/human immunodeficiency virus SHIV 89.6PD infection in macaques. J. Virol. 73, 10236-10244.
24. Zhou, D., Shen, Y., Chalifoux, L., Lee-Parritz, D., Simon, M., Sehgal, P. K., Zheng, L., Halloran, M., and Chen, Z. W. (1999). Mycobacterium bovis bacille Calmette-Guerin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: A role of persistent T cell activation in AIDS pathogenesis. J. Immunol. 162, 2204-2216.